BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 24148296)

  • 21. CD4+CD28- T cell expansion in granulomatosis with polyangiitis (Wegener's) is driven by latent cytomegalovirus infection and is associated with an increased risk of infection and mortality.
    Morgan MD; Pachnio A; Begum J; Roberts D; Rasmussen N; Neil DA; Bajema I; Savage CO; Moss PA; Harper L
    Arthritis Rheum; 2011 Jul; 63(7):2127-37. PubMed ID: 21437878
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD56+ T cells are increased in kidney transplant patients following cytomegalovirus infection.
    Almehmadi M; Hammad A; Heyworth S; Moberly J; Middleton D; Hopkins MJ; Hart IJ; Christmas SE
    Transpl Infect Dis; 2015 Aug; 17(4):518-26. PubMed ID: 26039898
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Emergence of a CD4+CD28- granzyme B+, cytomegalovirus-specific T cell subset after recovery of primary cytomegalovirus infection.
    van Leeuwen EM; Remmerswaal EB; Vossen MT; Rowshani AT; Wertheim-van Dillen PM; van Lier RA; ten Berge IJ
    J Immunol; 2004 Aug; 173(3):1834-41. PubMed ID: 15265915
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rapid Acquisition of Cytomegalovirus-Specific T Cells with a Differentiated Phenotype, in Nonviremic Hematopoietic Stem Transplant Recipients Vaccinated with CMVPepVax.
    La Rosa C; Longmate J; Lingaraju CR; Zhou Q; Kaltcheva T; Hardwick N; Aldoss I; Nakamura R; Diamond DJ
    Biol Blood Marrow Transplant; 2019 Apr; 25(4):771-784. PubMed ID: 30562587
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of the CD4+ T cell response to Epstein-Barr virus during primary and persistent infection.
    Amyes E; Hatton C; Montamat-Sicotte D; Gudgeon N; Rickinson AB; McMichael AJ; Callan MF
    J Exp Med; 2003 Sep; 198(6):903-11. PubMed ID: 12975456
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of CMV-specific cytotoxic T cells (CMV-Tc) in pediatric renal transplant recipients with CMV viremia.
    Pizzo H; Shin B; Garrison J; Huang E; Malekzadeh M; Jordan SC; Puliyanda D; Toyoda M
    Pediatr Transplant; 2021 Dec; 25(8):e14119. PubMed ID: 34390094
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CMV specific T cell immune response in hepatitis C negative kidney transplant recipients receiving transplant from hepatitis C viremic donors and hepatitis C aviremic donors.
    Azhar A; Tsujita M; Talwar M; Balaraman V; Bhalla A; Eason JD; Nouer SS; Sumida K; Remport A; Hall IE; Griffin R; Rofaiel G; Molnar MZ
    Ren Fail; 2022 Dec; 44(1):831-841. PubMed ID: 35546431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD28
    Pera A; Caserta S; Albanese F; Blowers P; Morrow G; Terrazzini N; Smith HE; Rajkumar C; Reus B; Msonda JR; Verboom M; Hallensleben M; Blasczyk R; Davies KA; Kern F
    Theranostics; 2018; 8(16):4509-4519. PubMed ID: 30214635
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CMV Status Drives Distinct Trajectories of CD4+ T Cell Differentiation.
    Zhang W; Morris AB; Peek EV; Karadkhele G; Robertson JM; Kissick HT; Larsen CP
    Front Immunol; 2021; 12():620386. PubMed ID: 33936035
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rapid T cell repopulation after rabbit anti-thymocyte globulin (rATG) treatment is driven mainly by cytomegalovirus.
    Havenith SH; Remmerswaal EB; Bemelman FJ; Yong SL; van Donselaar-van der Pant KA; van Lier RA; Ten Berge IJ
    Clin Exp Immunol; 2012 Sep; 169(3):292-301. PubMed ID: 22861369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship of reconstituted adaptive and innate cytomegalovirus (CMV)-specific immune responses with CMV viremia in hematopoietic stem cell transplant recipients.
    Barron MA; Gao D; Springer KL; Patterson JA; Brunvand MW; McSweeney PA; Zeng C; BarĂ³n AE; Weinberg A
    Clin Infect Dis; 2009 Dec; 49(12):1777-83. PubMed ID: 19911937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protective immunity to cytomegalovirus (CMV) retinitis in AIDS is associated with CMV-specific T cells that express interferon- gamma and interleukin-2 and have a CD8+ cell early maturational phenotype.
    Sinclair E; Tan QX; Sharp M; Girling V; Poon C; Natta MV; Jabs DA; Inokuma M; Maecker HT; Bredt B; Jacobson MA;
    J Infect Dis; 2006 Dec; 194(11):1537-46. PubMed ID: 17083038
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recall response to cytomegalovirus in allograft recipients: mobilization of CD57+, CD28+ cells before expansion of CD57+, CD28- cells within the CD8+ T lymphocyte compartment.
    Hazzan M; Labalette M; Noel C; Lelievre G; Dessaint JP
    Transplantation; 1997 Mar; 63(5):693-8. PubMed ID: 9075840
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differentiation of cytomegalovirus-specific CD8(+) T cells in healthy and immunosuppressed virus carriers.
    Gamadia LE; Rentenaar RJ; Baars PA; Remmerswaal EB; Surachno S; Weel JF; Toebes M; Schumacher TN; ten Berge IJ; van Lier RA
    Blood; 2001 Aug; 98(3):754-61. PubMed ID: 11468176
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CMV seropositivity determines epoetin dose and hemoglobin levels in patients with CKD.
    Betjes MG; Weimar W; Litjens NH
    J Am Soc Nephrol; 2009 Dec; 20(12):2661-6. PubMed ID: 19820127
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Understanding the mechanism of action of cytomegalovirus-induced regulatory T cells.
    Tovar-Salazar A; Weinberg A
    Virology; 2020 Aug; 547():1-6. PubMed ID: 32442104
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low cytomegalovirus-specific T-cell counts at reactivation are associated with progression to high-level viremia or disease in seropositive recipients of hematopoietic cell grafts from seropositive but not seronegative donors.
    Hoegh-Petersen M; Roa L; Liu Y; Zhou F; Ugarte-Torres A; Louie P; Fonseca K; Khan F; Russell JA; Storek J
    Cytotherapy; 2012 Feb; 14(2):194-204. PubMed ID: 22149135
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HIV-1-specific memory CD4+ T cells are phenotypically less mature than cytomegalovirus-specific memory CD4+ T cells.
    Yue FY; Kovacs CM; Dimayuga RC; Parks P; Ostrowski MA
    J Immunol; 2004 Feb; 172(4):2476-86. PubMed ID: 14764720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD27-CD70 costimulation controls T cell immunity during acute and persistent cytomegalovirus infection.
    Welten SP; Redeker A; Franken KL; Benedict CA; Yagita H; Wensveen FM; Borst J; Melief CJ; van Lier RA; van Gisbergen KP; Arens R
    J Virol; 2013 Jun; 87(12):6851-65. PubMed ID: 23576505
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary Cytomegalovirus Infection Significantly Impacts Circulating T Cells in Kidney Transplant Recipients.
    Meijers RW; Litjens NH; Hesselink DA; Langerak AW; Baan CC; Betjes MG
    Am J Transplant; 2015 Dec; 15(12):3143-56. PubMed ID: 26211927
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.